Windsor Wealth Management’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,912
Closed -$432K 195
2020
Q3
$432K Buy
+4,912
New +$248K 0.13% 136
2019
Q3
Sell
-13,500
Closed -$190K 190
2019
Q2
$190K Buy
+13,500
New +$203K 0.08% 174

Windsor Wealth Management's IMMU Position: Q4 2020 in Review

Windsor Wealth Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,912 shares — an estimated $432K sold.

Windsor Wealth Management first reported a position in IMMU in Q2 2019 and held it in 2 quarters. The position peaked at $432K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Windsor Wealth Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Windsor Wealth Management sold 4,912 Immunomedics Inc shares in Q4 2020, an estimated $432K.
  • Windsor Wealth Management first reported a position in Immunomedics Inc in Q2 2019 and held it in 2 quarters.
  • Windsor Wealth Management's Immunomedics Inc position peaked at $432K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Windsor Wealth Management's 13F filing for Q4 2020, filed 9 Feb 2021.